GnRH antagonists and endometrial receptivity in oocyte recipients: a prospective randomized trial

Author： Prapas Nikos Tavaniotou Asimina Panagiotidis Yannis Prapa Stella Kasapi Evangelia Goudakou Maria Papatheodorou Achilleas Prapas Yannis

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.18, Iss.2, 2009-02, pp. : 276-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study

By Melo M Busso CE Bellver J Alama P Garrido N Meseguer M Pellicer A Remohí J

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 486-492

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH antagonists in IVF

By Kolibianakis Efstratios M Tarlatzis Basil Devroey Paul

Reproductive BioMedicine Online, Vol. 10, Iss. 6, 2005-06 ,pp. : 705-712

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ Caglar GS Sozen E Akarsu C Tuncay G Ozbıcer T Vicdan K

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH antagonist in IVF poor-responder patients: results of a randomized trial

By Marci Roberto Caserta Donatella Dolo Vincenza Tatone Carla Pavan Antonio Moscarini Massimo

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 189-193

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Safety of GnRH agonists and antagonists

By Tarlatzis Basil C Bili Helen

Expert Opinion on Drug Safety, Vol. 3, Iss. 1, 2004-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite